Evaluation of a pharmacist-led medication review and optimisation service in the management of cardiometabolic disease
The pharmacist-led service was feasible to deliver, acceptable to patients and supported the operationalisation of guideline-directed SGLT2i prescribing. Further longitudinal studies are needed to determine clinical and economic outcomes.
Authors
- Glenda Fleming (ORCID: https://orcid.org/0000-0001-7321-8092)
- S Gardner
- Monica Monaghan
- Rachel Glass
- Pauline Coleman
- Barry Keenan
- Michael G Scott
Publication Details
- Journal
- European Journal of Hospital Pharmacy
- Published
- 2026-03-11
- DOI
- https://doi.org/10.1136/ejhpharm-2025-004897
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00